Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

HPV-6-targeting Immunotherapeutic Vaccine INO-3106

Known as: HPV-6 E6/E7 DNA Vaccine INO-3106, HPV-6-targeting Immunotherapeutic INO-3106, INO-3106 
A DNA vaccine consisting of plasmids encoding the E6 and E7 genes of human papilloma virus subtype 6 (HPV-6), with potential immunostimulating and… Expand
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2020
2020
Immune Therapy Targeting E6/E7 Oncogenes of Human Papillomavirus Type 6 (HPV-6) Reduces or Eliminates the Need for Surgical Intervention in the Treatment of HPV-6 Associated Recurrent Respiratory…
Background: Recurrent respiratory papillomatosis (RRP) is a rare disorder characterized by the generation of papillomas of the… Expand
  • figure 3
  • figure 4
2019
2019
Indoleamine 2, 3-dioxygenase inhibitors in immunochemotherapy of breast cancer: challenges and opportunities
Summary Trafficking of macromolecular immunotherapy agent into the tumor microenvironment (TME) is a challenging issue. In the… Expand
  • figure 1
2019
2019
Sono-Immunotherapeutic Nanocapturer to Combat Multidrug-Resistant Bacterial Infections.
Antibiotic-free methods hold particular promise for preventing and controlling multidrug-resistant (MDR) bacterial infection via… Expand
2016
2016
[Correlation between high risk type human papillomavirus E6/E7 mRNA and cervical cancer].
OBJECTIVE To investigate the correlation between the positive rate of high risk human papillomavirus(HPV)mRNA E6/E7 and cervical… Expand
2012
2012
Cancer Therapy : Preclinical Stem-like Tumor-Initiating Cells Isolated from IL 13 R a 2 Expressing Gliomas Are Targeted and Killed by IL 13-Zetakine – Redirected T Cells
Purpose: To evaluate IL13Ra2 as an immunotherapeutic target for eliminating glioma stem–like cancer initiating cells (GSC) of… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Highly Cited
2008
Highly Cited
2008
Clinical significance of B7-H1（PD-L1）expression in human acute leukemia
B7-H1 (B7 homologue 1, PD-L1), expressed on the surface of tumor cells or antigen-presenting cells in the tumor microenvironment… Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE